Japan Intellectual Property Rights: COMPOSITIONS AND METHODS FOR TREATING CANCER WITH SELF-DRIVING CHIMERIC ANTIGEN RECEPTORS

Japan, Sept. 30 -- LENTIGEN TECHNOLOGY INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR TREATING CANCER WITH SELF-DRIVING CHIMERIC ANTIGEN RECEPTORS.' Other related details are as follows:

Application Number: JP,2025-037065

Category (FI): C12N5/0783,C12N5/10,C12N1/21,C12N1/19,C12N1/15,C12N15/861@Z,C12N15/867@Z,C12N15/869@Z,C07K16/28,C07K19/00,C12N15/62@Z,C12N15/13,C12N15/11@Z,A61P35/00,A61K39/395@T,A61K47/68,C07K14/705,C12N15/12,C12N15/85@Z,A61K40/42,A61K40/11,A61K40/31,A61P37/04,A61K35/76,A61P35/02,C12P21/08

Stage: Grant (IP right granted following substantive examination.)

Filing Date: March 10, 2025

Publication Date: July 23, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.